Show simple item record

dc.contributor.authorPratt, Guy
dc.date.accessioned2025-01-09T12:22:07Z
dc.date.available2025-01-09T12:22:07Z
dc.date.issued2020-08-04
dc.identifier.citationPratt G. Bortezomib, Melphalan, Dexamethasone: A New Standard of Care for AL Amyloidosis? J Clin Oncol. 2020 Oct 1;38(28):3243-3244. doi: 10.1200/JCO.20.01904. Epub 2020 Aug 4.en_US
dc.identifier.issn0732-183X
dc.identifier.eissn1527-7755
dc.identifier.doi10.1200/JCO.20.01904
dc.identifier.pmid32749940
dc.identifier.urihttp://hdl.handle.net/20.500.14200/6889
dc.description.abstractNo abstract availableen_US
dc.language.isoenen_US
dc.publisherAmerican Society of Clinical Oncologyen_US
dc.relation.urlhttps://ascopubs.org/journal/jcoen_US
dc.subjectOncology. Pathology.en_US
dc.subjectHaematologyen_US
dc.titleBortezomib, melphalan, dexamethasone: a new standard of care for AL amyloidosis?en_US
dc.typeArticleen_US
dc.source.journaltitleJournal of Clinical Oncologyen_US
dc.source.volume38
dc.source.issue28
dc.source.beginpage3243
dc.source.endpage3244
dc.source.countryUnited States
rioxxterms.versionNAen_US
dc.contributor.trustauthorPratt, Guy
dc.contributor.departmentHaematologyen_US
dc.contributor.roleMedical and Dentalen_US
dc.contributor.affiliationUniversity Hospitals Birmingham NHS Foundation Trusten_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record